BR112021020143A2 - Integração de construções de ácidos nucleicos com células eucarióticas com uma transposase de oryzias - Google Patents
Integração de construções de ácidos nucleicos com células eucarióticas com uma transposase de oryziasInfo
- Publication number
- BR112021020143A2 BR112021020143A2 BR112021020143A BR112021020143A BR112021020143A2 BR 112021020143 A2 BR112021020143 A2 BR 112021020143A2 BR 112021020143 A BR112021020143 A BR 112021020143A BR 112021020143 A BR112021020143 A BR 112021020143A BR 112021020143 A2 BR112021020143 A2 BR 112021020143A2
- Authority
- BR
- Brazil
- Prior art keywords
- oryzia
- transposase
- integration
- nucleic acid
- eukaryotic cells
- Prior art date
Links
- 102000008579 Transposases Human genes 0.000 title abstract 3
- 108010020764 Transposases Proteins 0.000 title abstract 3
- 108020004707 nucleic acids Proteins 0.000 title abstract 3
- 102000039446 nucleic acids Human genes 0.000 title abstract 3
- 150000007523 nucleic acids Chemical class 0.000 title abstract 3
- 241000276568 Oryzias Species 0.000 title abstract 2
- 210000003527 eukaryotic cell Anatomy 0.000 title abstract 2
- 230000010354 integration Effects 0.000 title abstract 2
- 108090000623 proteins and genes Proteins 0.000 abstract 4
- 230000014509 gene expression Effects 0.000 abstract 3
- 239000013598 vector Substances 0.000 abstract 3
- 238000010364 biochemical engineering Methods 0.000 abstract 1
- 210000004027 cell Anatomy 0.000 abstract 1
- 238000001415 gene therapy Methods 0.000 abstract 1
- 238000002743 insertional mutagenesis Methods 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 102000040430 polynucleotide Human genes 0.000 abstract 1
- 108091033319 polynucleotide Proteins 0.000 abstract 1
- 239000002157 polynucleotide Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/67—General methods for enhancing the expression
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/52—Genes encoding for enzymes or proenzymes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
- C12N15/1034—Isolating an individual clone by screening libraries
- C12N15/1082—Preparation or screening gene libraries by chromosomal integration of polynucleotide sequences, HR-, site-specific-recombination, transposons, viral vectors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/62—DNA sequences coding for fusion proteins
- C12N15/625—DNA sequences coding for fusion proteins containing a sequence coding for a signal sequence
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/80—Vectors or expression systems specially adapted for eukaryotic hosts for fungi
- C12N15/81—Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/8509—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells for producing genetically modified animals, e.g. transgenic
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/0004—Oxidoreductases (1.)
- C12N9/0012—Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.6, 1.7)
- C12N9/0026—Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.6, 1.7) acting on CH-NH groups of donors (1.5)
- C12N9/0028—Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.6, 1.7) acting on CH-NH groups of donors (1.5) with NAD or NADP as acceptor (1.5.1)
- C12N9/003—Dihydrofolate reductase [DHFR] (1.5.1.3)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/1025—Acyltransferases (2.3)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/1025—Acyltransferases (2.3)
- C12N9/1029—Acyltransferases (2.3) transferring groups other than amino-acyl groups (2.3.1)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
- C12N9/1205—Phosphotransferases with an alcohol group as acceptor (2.7.1), e.g. protein kinases
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
- C12N9/1241—Nucleotidyltransferases (2.7.7)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/93—Ligases (6)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y105/00—Oxidoreductases acting on the CH-NH group of donors (1.5)
- C12Y105/01—Oxidoreductases acting on the CH-NH group of donors (1.5) with NAD+ or NADP+ as acceptor (1.5.1)
- C12Y105/01003—Dihydrofolate reductase (1.5.1.3)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y207/00—Transferases transferring phosphorus-containing groups (2.7)
- C12Y207/01—Phosphotransferases with an alcohol group as acceptor (2.7.1)
- C12Y207/01119—Hygromycin-B 7''-O-kinase (2.7.1.119)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y207/00—Transferases transferring phosphorus-containing groups (2.7)
- C12Y207/07—Nucleotidyltransferases (2.7.7)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y603/00—Ligases forming carbon-nitrogen bonds (6.3)
- C12Y603/01—Acid-ammonia (or amine)ligases (amide synthases)(6.3.1)
- C12Y603/01002—Glutamate-ammonia ligase (6.3.1.2)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2800/00—Nucleic acids vectors
- C12N2800/90—Vectors containing a transposable element
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2830/00—Vector systems having a special element relevant for transcription
- C12N2830/007—Vector systems having a special element relevant for transcription cell cycle specific enhancer/promoter combination
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2830/00—Vector systems having a special element relevant for transcription
- C12N2830/42—Vector systems having a special element relevant for transcription being an intron or intervening sequence for splicing and/or stability of RNA
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2840/00—Vectors comprising a special translation-regulating system
- C12N2840/20—Vectors comprising a special translation-regulating system translation of more than one cistron
- C12N2840/203—Vectors comprising a special translation-regulating system translation of more than one cistron having an IRES
Landscapes
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Biomedical Technology (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Medicinal Chemistry (AREA)
- Mycology (AREA)
- Bioinformatics & Computational Biology (AREA)
- Crystallography & Structural Chemistry (AREA)
- Virology (AREA)
- Veterinary Medicine (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Enzymes And Modification Thereof (AREA)
- Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
ntegração de construções de ácidos nucleicos com células eucarióticas com uma transposase de oryzia. a presente invenção fornece vetores polinucleotídicos para alta expressão de genes heterólogos. alguns vetores compreendem adicionalmente novos transposons e transposases que melhoram ainda mais a expressão. além disso, são divulgados vetores que podem ser usados em um sistema de transferência de genes para a introdução estável de ácidos nucleicos no dna de uma célula. os sistemas de transferência de genes podem ser usados em métodos, por exemplo, expressão gênica, bioprocessamento, terapia gênica, mutagênese por inserção ou descoberta de genes.
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201962831092P | 2019-04-08 | 2019-04-08 | |
US201962873338P | 2019-07-12 | 2019-07-12 | |
US202062982186P | 2020-02-27 | 2020-02-27 | |
PCT/US2020/027080 WO2020210239A1 (en) | 2019-04-08 | 2020-04-07 | Integration of nucleic acid constructs into eukaryotic cells with a transposase from oryzias |
Publications (1)
Publication Number | Publication Date |
---|---|
BR112021020143A2 true BR112021020143A2 (pt) | 2021-12-14 |
Family
ID=72663493
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR112021020143A BR112021020143A2 (pt) | 2019-04-08 | 2020-04-07 | Integração de construções de ácidos nucleicos com células eucarióticas com uma transposase de oryzias |
Country Status (11)
Country | Link |
---|---|
US (3) | US11060098B2 (pt) |
EP (1) | EP3953481A4 (pt) |
JP (1) | JP7418470B2 (pt) |
KR (1) | KR20210143897A (pt) |
CN (1) | CN112424362A (pt) |
AU (1) | AU2020272668B2 (pt) |
BR (1) | BR112021020143A2 (pt) |
CA (1) | CA3125047A1 (pt) |
IL (2) | IL287089B2 (pt) |
SG (1) | SG11202107416PA (pt) |
WO (1) | WO2020210239A1 (pt) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2311490A3 (en) | 1998-07-13 | 2011-05-04 | Board of Regents, The University of Texas System | Uses of antibodies to aminophospholipids for cancer treatment |
IL301621A (en) * | 2019-04-08 | 2023-05-01 | Dna Twopointo Inc | Transposition of nucleic acid constructs into eukaryotic genomes with amylase transposases |
CN112424362A (zh) | 2019-04-08 | 2021-02-26 | Dna2.0股份有限公司 | 使用来自青鳉属的转座酶将核酸构建体整合入真核细胞 |
EP3953480A4 (en) | 2019-04-08 | 2023-01-11 | Dna Twopointo Inc. | TRANSPOSITION OF NUCLEIC ACIDS INTO EUKARYOTIC GENOMES WITH A TRANSPOSASE FROM HELIOTHIS |
WO2021226141A1 (en) | 2020-05-04 | 2021-11-11 | Saliogen Therapeutics, Inc. | Transposition-based therapies |
US11566262B2 (en) * | 2021-03-24 | 2023-01-31 | Dna Twopointo Inc. | Tetracycline-inducible expression systems |
WO2023060089A2 (en) * | 2021-10-04 | 2023-04-13 | Poseida Therapeutics, Inc. | Transposases and uses thereof |
CN114045305B (zh) * | 2021-10-15 | 2023-03-24 | 深圳市深研生物科技有限公司 | 多转座子系统 |
CN116445542A (zh) * | 2022-01-10 | 2023-07-18 | 佛山汉腾生物科技有限公司 | 表达载体及其应用 |
CN115521899A (zh) * | 2022-05-06 | 2022-12-27 | 西南大学 | 一种高效的日本青鱂体外培养细胞CRISPR/Cas9基因组编辑方法及其应用 |
WO2024068995A1 (en) | 2022-09-30 | 2024-04-04 | Boehringer Ingelheim International Gmbh | Novel transposase system |
Family Cites Families (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7560542B2 (en) * | 1999-05-07 | 2009-07-14 | Monsanto Technology Llc | Nucleic acid molecule SEQ ID NO. 68811 and other molecules associated with plants |
JP4629162B2 (ja) * | 1999-12-03 | 2011-02-09 | 独立行政法人科学技術振興機構 | トランスポゾン転移酵素および遺伝子改変方法 |
US7932088B1 (en) | 2005-04-25 | 2011-04-26 | University Of Notre Dame Du Lac | High efficiency transformation of Plasmodium falciparum by the lepidopteran transposon, piggyBac |
WO2006122442A1 (en) * | 2005-05-14 | 2006-11-23 | Fudan University | Piggybac as a tool for genetic manipulation and analysis in vertebrates |
JP4588681B2 (ja) * | 2006-09-15 | 2010-12-01 | 株式会社日立国際電気 | 無線基地局 |
JP5320546B2 (ja) * | 2006-12-13 | 2013-10-23 | 国立大学法人名古屋大学 | Tol1因子のトランスポザーゼ及びそれを用いたDNA導入システム |
EP2160461B1 (en) * | 2007-07-04 | 2012-08-08 | Max-Delbrück-Centrum für Molekulare Medizin (MDC) | Hyperactive variants of the transposase protein of the transposon system sleeping beauty |
JP5897335B2 (ja) * | 2009-01-23 | 2016-03-30 | エヌエスジーン・アクティーゼルスカブNsGene A/S | 改良された細胞株及びカプセル化細胞生体送達におけるその使用 |
SG174155A1 (en) | 2009-02-25 | 2011-10-28 | Univ Johns Hopkins | Piggybac transposon variants and methods of use |
CN106978441A (zh) * | 2009-06-11 | 2017-07-25 | 大学共同利用机关法人情报·系统研究机构 | 生产蛋白质的方法 |
AU2013204327B2 (en) * | 2012-04-20 | 2016-09-01 | Aviagen | Cell transfection method |
JP2014230515A (ja) * | 2013-05-29 | 2014-12-11 | 国立大学法人 東京大学 | 新規なトランスポゾン転移酵素 |
US10233454B2 (en) * | 2014-04-09 | 2019-03-19 | Dna2.0, Inc. | DNA vectors, transposons and transposases for eukaryotic genome modification |
US9428767B2 (en) * | 2014-04-09 | 2016-08-30 | Dna2.0, Inc. | Enhanced nucleic acid constructs for eukaryotic gene expression |
EP3359671B1 (en) * | 2015-10-08 | 2021-08-18 | Dna Twopointo Inc. | Dna vectors, transposons and transposases for eukaryotic genome modification |
IL301621A (en) * | 2019-04-08 | 2023-05-01 | Dna Twopointo Inc | Transposition of nucleic acid constructs into eukaryotic genomes with amylase transposases |
CN112424362A (zh) | 2019-04-08 | 2021-02-26 | Dna2.0股份有限公司 | 使用来自青鳉属的转座酶将核酸构建体整合入真核细胞 |
EP3953480A4 (en) | 2019-04-08 | 2023-01-11 | Dna Twopointo Inc. | TRANSPOSITION OF NUCLEIC ACIDS INTO EUKARYOTIC GENOMES WITH A TRANSPOSASE FROM HELIOTHIS |
EP3969462A4 (en) * | 2019-05-13 | 2023-01-18 | Dna Twopointo Inc. | MODIFICATIONS OF MAMMALIAN CELLS USING ARTIFICIAL MICRORNA TO MODIFY THEIR PROPERTIES AND COMPOSITIONS OF THEIR PRODUCTS |
CN117015600A (zh) * | 2020-07-17 | 2023-11-07 | 普罗拜奥根股份公司 | 高活性转座子和转座酶 |
-
2020
- 2020-04-07 CN CN202080003848.3A patent/CN112424362A/zh active Pending
- 2020-04-07 SG SG11202107416PA patent/SG11202107416PA/en unknown
- 2020-04-07 IL IL287089A patent/IL287089B2/en unknown
- 2020-04-07 KR KR1020217035083A patent/KR20210143897A/ko not_active Application Discontinuation
- 2020-04-07 EP EP20788172.3A patent/EP3953481A4/en active Pending
- 2020-04-07 CA CA3125047A patent/CA3125047A1/en active Pending
- 2020-04-07 IL IL301620A patent/IL301620A/en unknown
- 2020-04-07 AU AU2020272668A patent/AU2020272668B2/en active Active
- 2020-04-07 JP JP2021560153A patent/JP7418470B2/ja active Active
- 2020-04-07 WO PCT/US2020/027080 patent/WO2020210239A1/en unknown
- 2020-04-07 BR BR112021020143A patent/BR112021020143A2/pt unknown
- 2020-04-07 US US16/842,719 patent/US11060098B2/en active Active
-
2021
- 2021-06-04 US US17/339,617 patent/US11401521B2/en active Active
-
2022
- 2022-06-03 US US17/832,409 patent/US20230103199A1/en active Pending
Also Published As
Publication number | Publication date |
---|---|
JP2022527017A (ja) | 2022-05-27 |
IL301620A (en) | 2023-05-01 |
CA3125047A1 (en) | 2020-10-15 |
IL287089B1 (en) | 2023-05-01 |
US11060098B2 (en) | 2021-07-13 |
WO2020210239A1 (en) | 2020-10-15 |
AU2020272668A1 (en) | 2021-07-15 |
IL287089B2 (en) | 2023-09-01 |
EP3953481A4 (en) | 2023-01-25 |
US20210292773A1 (en) | 2021-09-23 |
KR20210143897A (ko) | 2021-11-29 |
EP3953481A1 (en) | 2022-02-16 |
US20230103199A1 (en) | 2023-03-30 |
AU2020272668B2 (en) | 2023-07-06 |
CN112424362A (zh) | 2021-02-26 |
US20200318121A1 (en) | 2020-10-08 |
IL287089A (en) | 2021-12-01 |
US11401521B2 (en) | 2022-08-02 |
JP7418470B2 (ja) | 2024-01-19 |
SG11202107416PA (en) | 2021-08-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR112021020143A2 (pt) | Integração de construções de ácidos nucleicos com células eucarióticas com uma transposase de oryzias | |
BR112021020144A2 (pt) | Transposição de construções de ácidos nucleicos em genomas eucarióticos com uma transposase de amyelois | |
US11913040B2 (en) | Evolution of TALENs | |
BR112021012665A2 (pt) | Polipeptídeos úteis para edição de genes e métodos de uso | |
WO2017062668A3 (en) | Dna vectors, transposons and transposases for eukaryotic genome modification | |
US9863933B2 (en) | Method for determining the repair activity of non-homologous end joining | |
JP2023002712A (ja) | S.ピオゲネスcas9変異遺伝子及びこれによってコードされるポリペプチド | |
US11242542B2 (en) | S. pyogenes Cas9 mutant genes and polypeptides encoded by same | |
EP4321617A3 (en) | Crispr/cpf1 systems and methods | |
BR112020024863A2 (pt) | Nucleases guiadas por rna, fragmentos ativos e variantes das mesmas e métodos de uso | |
CL2021002742A1 (es) | Una proteína crispr de prevotella y francisella 1 (cpf1) aislada de francisella tularensis; proteína de fusión que la comprende; ácido nucleico; vector; métodos para alterar el genoma de una célula o una molécula de adn bicatenario in vitro que utilizan dichas proteínas (divisional de sol. 201903004) | |
BR112019012183A2 (pt) | métodos de modificar o material genético de uma célula eucariótica e de um organismo, vetor de expressão de polinucleotídeo, e, célula procariótica. | |
US20170349905A1 (en) | Genome editing with split cas9 expressed from two vectors | |
Chen et al. | CRISPR-Cas9: from genome editing to cancer research | |
EA201892810A1 (ru) | Гибридные последовательности нуклеиновых кислот для геномной инженерии | |
BR112019006388A2 (pt) | enzimas modificadoras de ácido nucleico guiadas por rna e métodos de uso das mesmas | |
WO2018188571A1 (zh) | 基因组编辑系统和方法 | |
ES2690386T3 (es) | Composición para escindir un ADN diana que comprende un ARN guía específico para el ADN diana y el ácido nucleico que codifica la proteína Cas o la propia proteína Cas, y sus usos | |
WO2010085699A3 (en) | Mammalian piggybac transposon and methods of use | |
Zhang et al. | Improving the specificity and efficacy of CRISPR/CAS9 and gRNA through target specific DNA reporter | |
BR112022002695A2 (pt) | Nucleases guiadas por rna, fragmentos ativos e variantes das mesmas e métodos de uso | |
BR112018067536A2 (pt) | sistema de transpóson e métodos de uso | |
MX2019014516A (es) | Metodo para eliminar el gen objetivo en celulas t in vitro y arncr utilizado en el metodo. | |
Lee et al. | Protein–DNA photo-crosslinking with a genetically encoded benzophenone-containing amino acid | |
BR112018016443A2 (pt) | sistema de transposon replicativo |